건선 및 건선관절염에서 임상 양상과 동반질환에 대한 후향적 비교연구 = A Comparison of the Clinical Features and Comorbidities of Psoriasis and Psoriatic Arthritis: A Retrospective Study

다국어 초록 (Multilingual Abstract)

Background: Psoriatic arthritis (PsA) is one of the inflammatory arthritis associated with psoriasis. Several studies have described the clinical difference between psoriatic patients with PsA and those without PsA. Objective: The purpose of this study was to examine the difference in clinical features and prevalence of comorbidities between psoriatic patients with and without PsA in Korea. Methods: We retrospectively evaluated 173 patients diagnosed with psoriasis. Patients were subdivided based on the presence or absence of PsA. We analyzed clinical manifestations including comorbidities and laboratory tests such as total cholesterol, triglyceride, C-reactive protein, erythrocyte sedimentation rate (ESR), and fasting glucose. Results: Among 173 patients with psoriasis, 29 patients (16.8%) were diagnosed with PsA. The mean age of psoriasis onset for patients with PsA was 7.6 years earlier (p=0.017) than for those without PsA. The duration of psoriasis was 4.6 years longer (p＜0.001) in patients with PsA than in patients without PsA. Nail involvement was more common in patients with PsA (p＜0.001). There were statistically significant differences between the two groups regarding ESR levels (p=0.003) and the prevalence of diabetes mellitus (p=0.032). Conclusion: We found several differences in the prevalence of comorbidities, levels of inflammatory markers, and epidemiologic characteristics between psoriatic patients with and without PsA. This study may help improve strategies for the clinical approach for treating psoriasis in dermatology. (Korean J Dermatol 2016;54(8):608∼613)

참고문헌 (Reference)

1 윤재일, "한국인의 건선" 대한피부과학회 50 (50): 387-402, 2012

2 이성율, "한국인 건선환자에서 심ㆍ뇌혈관 질환 및 당뇨병 동반에 관한 후향적 연구" 대한피부과학회 50 (50): 688-692, 2012

3 최효진, "한국인 건선관절염 환자의 임상양상 및 성별에 따른 비교" 대한내과학회 74 (74): 418-425, 2008

4 이상원, "건선 관절염의 임상상과 진단" 대한내과학회 85 (85): 250-255, 2013

5 Stern RS, "The epidemiology of joint complaints in patients with psoriasis" 12 : 315-320, 1985

6 Baek HJ, "Spondylitis is the most common pattern of psoriatic arthritis in Korea" 19 : 89-94, 2000

7 유향석, "Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire" 대한피부과학회 27 (27): 265-268, 2015

8 Jones SM, "Psoriatic arthritis: Outcome of disease subsets and relationship of joint disease to nail and skin disease" 33 : 834-839, 1994

9 Scarpa R, "Psoriatic arthritis in psoriatic patients" 23 : 246-250, 1984

10 Moll JM, "Psoriatic arthritis" 3 : 55-78, 1973

11 Gonzalez-Gay MA, "Psoriasis: a skin disease associated with increased cardiovascular risk" 103 : 595-598, 2012

12 Qureshi AA, "Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses" 145 : 378-382, 2009

13 Ahlehoff O, "Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study" 33 : 2054-2064, 2012

14 Ciocon DH, "Psoriasis and psoriatic arthritis:separate or one and the same" 157 : 850-860, 2007

15 Azfar RS, "Psoriasis and metabolic disease: epidemiology and pathophysiology" 20 : 416-422, 2008

16 Margolis DJ, "Psoriasis and cardiovascular disease: and association or a reason to treat" 165 : 930-, 2011

17 Baek HJ, "Prevalence and clinical features of psoriatic arthritis in Korea" 5 : 193-204, 1998

18 Thumboo J, "Patterns of psoriatic arthritis in Orientals" 24 : 1949-1953, 1997

19 Mehta NN, "Patients with severe psoriasis are at risk of cardiovascular mortality: cohort study using the general practice research database" 31 : 1000-1006, 2010

20 Gladman DD, "HLA antigen in psoriatic arthritis" 13 : 586-592, 1986

21 Gudjonsson JE, "Fitzpatrick’s dermatology in general medicine" McGraw-Hill 197-231, 2012

22 Gladman DD, "Fitzpatrick’s dermatology in general medicine" McGraw-Hill 232-242, 2012

23 Reich K, "Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511patients with plaque-type psoriasis" 160 : 1040-1047, 2009

24 Kim KH, "Diseases Associated with Psoriasis : Multicenter study" 39 : 743-748, 2001

25 Maradit-Kramers H, "Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study" 26 : 336-343, 2012

26 Kim DY, "Clinical Features of Psoriatic Arthritis" 2 : 157-163, 1995

27 Taylor W, "Classification criteria for psoriatic arthritis:development of new criteria from a large international study" 54 : 2665-2673, 2006

28 Jamnitski A, "Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review" 72 : 211-216, 2012

29 Johnsson H, "Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence" 71 : 480-483, 2012

30 Luis Puig, "Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis" 26 : 7-15, 2015

31 Cohen MR, "Baseline relationship between psoriasis and psoriatic arthritis: analysis of 211 patients with active psoriatic arthritis" 26 : 1752-1756, 1999

32 Prodanovich S, "Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality" 145 : 700-703, 2009

33 Higgins E, "Alcohol, smoking and psoriasis" 25 : 107-110, 2000

34 Helliwell P, "A re-evaluation of the osteoarticular manifestations of psoriasis" 30 : 339-345, 1991